Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207164
Max Phase: Preclinical
Molecular Formula: C18H19N5O3
Molecular Weight: 353.38
Associated Items:
ID: ALA5207164
Max Phase: Preclinical
Molecular Formula: C18H19N5O3
Molecular Weight: 353.38
Associated Items:
Canonical SMILES: Cc1cccnc1Nc1nc(-c2ccc(OC3CCOCC3)cn2)no1
Standard InChI: InChI=1S/C18H19N5O3/c1-12-3-2-8-19-16(12)21-18-22-17(23-26-18)15-5-4-14(11-20-15)25-13-6-9-24-10-7-13/h2-5,8,11,13H,6-7,9-10H2,1H3,(H,19,21,22,23)
Standard InChI Key: GIOMFYDUUAVETN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 353.38 | Molecular Weight (Monoisotopic): 353.1488 | AlogP: 3.14 | #Rotatable Bonds: 5 |
Polar Surface Area: 95.19 | Molecular Species: ACID | HBA: 8 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 0.52 | CX Basic pKa: 5.93 | CX LogP: 2.90 | CX LogD: 1.35 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.75 | Np Likeness Score: -1.38 |
1. Hawryluk N, Robinson D, Shen Y, Kyne G, Bedore M, Menon S, Canan S, von Geldern T, Townson S, Gokool S, Ehrens A, Koschel M, Lhermitte-Vallarino N, Martin C, Hoerauf A, Hernandez G, Dalvie D, Specht S, Hübner MP, Scandale I.. (2022) Discovery of Substituted Di(pyridin-2-yl)-1,2,4-thiadiazol-5-amines as Novel Macrofilaricidal Compounds for the Treatment of Human Filarial Infections., 65 (16.0): [PMID:35972896] [10.1021/acs.jmedchem.2c00960] |
Source(1):